Analysts See $-0.03 EPS for ICC Labs Inc. (ICC)

August 13, 2018 - By James Douglas

Analysts expect ICC Labs Inc. (CVE:ICC) to report $-0.03 EPS on September, 4.They anticipate $0.02 EPS change or 200.00 % from last quarter’s $-0.01 EPS. After having $-0.08 EPS previously, ICC Labs Inc.’s analysts see -62.50 % EPS growth. The stock decreased 1.97% or $0.03 during the last trading session, reaching $1.49. About 132,939 shares traded. ICC Labs Inc. (CVE:ICC) has 0.00% since August 13, 2017 and is . It has underperformed by 12.57% the S&P500.

ICC Labs Inc. produces and sells cannabis in Uruguay. The company has market cap of $205.69 million. It offers recreational cannabis, cannabinoid extracts, and by-products for medicinal use, as well as industrial hemp. It has a 87.65 P/E ratio. The firm was formerly known as ICC International Cannabis Corporation and changed its name to ICC Labs Inc. in December 2017.

Receive News & Ratings Via Email - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings with our FREE daily email newsletter.